CEO, InfraTrac
University of Maryland Baltimore
Sharon Flank, Ph.D., InfraTrac CEO, is an innovator in additive manufacturing, including pharmaceutical dosing and release control, intellectual property protection, and quality management. InfraTrac's team collaborates with University of Maryland School of Pharmacy to develop 3D printing applications. She has a decade of experience creating AI solutions on the emerging technologies team at a defense contractor, followed by entrepreneurial experience in a fast-growing venture-backed company before founding InfraTrac in 2006. InfraTrac’s focus is on light-based innovations, with a specialty in pharmaceutical technologies.